Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic Cells

Semih U. Tareen(Metis Design Corporation (United States)), Scott H. Robbins(TRIA Bioscience (United States)), Christopher J. Nicolai(Metis Design Corporation (United States)), Neal Van Hoeven(Sana Biotechnology (United States)), Brenna Kelley-Clarke(Metis Design Corporation (United States)), Thomas W. Dubensky(Aduro BioTech (United States)), Derek D. Sloan(Fred Hutch Cancer Center), Megan M. Slough(Metis Design Corporation (United States)), Jared Odegard(Gilead Sciences (United States)), Linda Cassiano(Metis Design Corporation (United States)), Lisa Nelson(TRIA Bioscience (United States)), James M. Allen(Muscular Dystrophy Association), Chintan D. Vin(Metis Design Corporation (United States))
Molecular Therapy
December 6, 2013
Cited by 32


Related Papers